Sarah Neville

Sarah Neville is the Financial Times' global health editor, specialising in healthcare developments worldwide, from the NHS to emerging global health challenges including climate resilience and maternal health. With over 25 years at the FT, she has held senior editing and reporting roles including public policy editor, global pharmaceuticals editor and UK news editor, and was previously political editor at the Yorkshire Post and a Laurence Stern Fellow at the Washington Post. Her investigative work on austerity's impact earned a George Orwell Prize shortlist, and she has been a multiple finalist for health journalist of the year. Audiences gain sharp, evidence-based insights into healthcare policy, global health trends and the intersection of climate and public health.

When Sarah Neville joined a small investigative team examining austerity's devastating social impact, their work earned a shortlist for the George Orwell Prize for Exposing Britain's Social Evils. That 2016 recognition marked a defining moment in a journalism career spanning more than three decades, one built on rigorous reporting that holds power to account and illuminates the forces shaping public health. Now the Financial Times' global health editor, she has spent over 25 years with the paper, navigating senior roles from public policy editor and global pharmaceuticals editor to UK news editor and analysis editor. Her path to the FT began in regional newsrooms across northern England and Wales, progressed through political reporting at the Yorkshire Post, and included a prestigious 1995 Laurence Stern Fellowship at the Washington Post.

Sarah's authority in health journalism rests on sustained excellence and repeated industry recognition. She has been a finalist for health journalist of the year in the national press awards, often described as the Oscars of journalism, and was shortlisted for science and health journalist of the year in the British Journalism Awards. Her reporting spans the full spectrum of global healthcare developments, from the pressures facing the NHS to pharmaceutical industry dynamics and emerging public health challenges. More recently, her focus has expanded to the intersection of climate change and health outcomes, exploring how extreme heat threatens maternal health through increased risks of miscarriage, preterm birth and stillbirth in both tropical and temperate regions. She examines practical interventions such as India's heat action plans, community programmes in sub-Saharan Africa, and emerging UK guidance designed to protect pregnant women during hotter summers.

Audiences who engage with Sarah gain evidence-based perspectives that cut through complexity and reveal the real-world consequences of policy decisions. She equips organisations and decision-makers with the insight needed to understand how healthcare systems adapt under pressure, how climate resilience can be built into public health planning, and why community-led models matter when protecting vulnerable populations. Her work translates technical developments into accessible narratives that help leaders anticipate change, respond to emerging risks, and make informed choices about the future of health. Whether addressing global health trends, climate impacts on wellbeing, or the evolving challenges facing healthcare systems worldwide, Sarah delivers clarity grounded in decades of investigative rigour and a commitment to stories that matter.